HyTherCaP.: Hydralazine: A new therapeutic approach in Castration Resistant Prostate Carcinoma (Q2906475): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: modifying budgets in portugal one item from slovenia) |
(Changed label, description and/or aliases in fr: Adding French translations) |
||
| label / fr | label / fr | ||
HyTherCaP.: Hydralazine: une nouvelle approche thérapeutique dans le carcinome de la prostate résistant à la Castration | |||
Revision as of 19:20, 5 December 2021
Project Q2906475 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | HyTherCaP.: Hydralazine: A new therapeutic approach in Castration Resistant Prostate Carcinoma |
Project Q2906475 in Portugal |
Statements
203,999.0 Euro
0 references
239,999.0 Euro
0 references
85.0 percent
0 references
1 January 2018
0 references
30 June 2021
0 references
INSTITUTO PORTUGUÊS DE ONCOLOGIA DO PORTO FRANCISCO GENTIL - E.P.E.
0 references
Q2997125 (Deleted Item)
0 references
Identifiers
POCI-01-0145-FEDER-029030
0 references